Principal Investigator
Camillo Ricordi
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20221256
Clinical Trial Summary
Clinical Trial to Evaluate the Safety and Efficacy of CELZ-201 in Patients with Recent Onset Type 1 Diabetes
Phase
Phase I/II
Funding Agency/Sponsor
Industry
Disease
Diabetes (Type I)
Contact Information
Study Contact
Burlett Masters
Phone Number
+1 (305) 2435354
Email
bmasters2@miami.edu